Clinical Trial Update: Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed [Phase 3]

View source ↗

Summary

This Phase 3 trial update evaluates the long-term safety and efficacy of olanzapine in Bipolar I Disorder with depressive episodes. The study is completed, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Zyprexa (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2011-06-27